Literature DB >> 26452982

Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.

Emmanuelle Le Moigne1, Cecile Tromeur2, Aurelien Delluc2, Maelenn Gouillou3, Zarrin Alavi3, Karine Lacut4, Dominique Mottier4, Gregoire Le Gal4.   

Abstract

Entities:  

Keywords:  cohort study; contraception; progesterone; recurrence; venous thromboembolism

Mesh：

Substances：

Year:  2015        PMID： 26452982      PMCID： PMC4697900          DOI： 10.3324/haematol.2015.134882

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

Review 1.  Mechanisms of sex steroids. Future developments.

Authors:  Herbert Kuhl
Journal:  Maturitas       Date:  2004-04-15       Impact factor: 4.342

2.  Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.

Authors:  Hélène Vaillant-Roussel; Lemlih Ouchchane; Claire Dauphin; Pierre Philippe; Marc Ruivard
Journal:  Contraception       Date:  2011-08-04       Impact factor: 3.375

3.  Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event.

Authors:  S C Christiansen; W M Lijfering; F M Helmerhorst; F R Rosendaal; S C Cannegieter
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

4.  Lipid lowering drugs and the risk of recurrent venous thromboembolism.

Authors:  Aurélien Delluc; Cécile Tromeur; Emmanuelle Le Moigne; Emmanuel Nowak; Dominique Mottier; Grégoire Le Gal; Karine Lacut
Journal:  Thromb Res       Date:  2012-08-30       Impact factor: 3.944

5.  Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.

Authors:  Michel K Barsoum; John A Heit; Aneel A Ashrani; Cynthia L Leibson; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Res       Date:  2010-09-15       Impact factor: 3.944

6.  Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.

Authors:  K M Diab; M M Zaki
Journal:  J Obstet Gynaecol Res       Date:  2000-02       Impact factor: 1.730

7.  The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.

Authors:  Astrid van Hylckama Vlieg; Frans M Helmerhorst; Frits R Rosendaal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

8.  Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.

Authors:  Angeles Blanco-Molina; Javier Trujillo-Santos; Raimundo Tirado; Inmaculada Cañas; Antoni Riera; Mariano Valdés; Manuel Monreal
Journal:  Thromb Haemost       Date:  2009-03       Impact factor: 5.249

Review 9.  Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.

Authors:  S Mantha; R Karp; V Raghavan; N Terrin; K A Bauer; J I Zwicker
Journal:  BMJ       Date:  2012-08-07

10.  Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Authors:  Øjvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Finn Egil Skjeldestad; Ellen Løkkegaard
Journal:  BMJ       Date:  2011-10-25
View more
  1 in total

Review 1.  Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS.

Authors:  Lisa R Sammaritano
Journal:  Curr Rheumatol Rep       Date:  2021-04-30       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.